103 episodes
JAMA Cardiology Author Interviews JAMA Network
-
- Health & Fitness
Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide.
JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.
-
Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction
Interview with Sanjiv J. Shah, MD, author of Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. Hosted by James E. Udelson, MD.
Related Content:
Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction -
A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I
Interview with Gaurav A. Upadhyay, MD, and Jeremy S. Treger, MD, PhD, authors of A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I. Hosted by Kristen K. Patton, MD.
Related Content:
A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I -
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV
Interview with Michael T. Lu, MD, MPH, author of Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial, and Matthew J. Feinstein, MD, MSc, author of Statins, Inflammation, and Tissue Context in REPRIEVE. Hosted by Robert Bonow, MD.
Related Content:
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV Statins, Inflammation, and Tissue Context in REPRIEVE -
Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy
Interview with Sanjiv J. Shah, MD, author of Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial. Hosted by James E. Udelson, MD.
Related Content:
Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy -
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD.
Related Content:
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive -
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020
Interview with Muthiah Vaduganathan, MD, MPH, and John W. Ostrominski, MD, authors of Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020. Hosted by Sadiya Sana Khan, MD, MSc.
Related Content:
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020